Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 308

1.

Body mass index does not affect postoperative morbidity and oncologic outcomes of total mesorectal excision for rectal adenocarcinoma.

Ballian N, Yamane B, Leverson G, Harms B, Heise CP, Foley EF, Kennedy GD.

Ann Surg Oncol. 2010 Jun;17(6):1606-13. doi: 10.1245/s10434-010-0908-4. Epub 2010 Jan 15.

PMID:
20077020
2.
3.

Visceral obesity is associated with outcomes of total mesorectal excision for rectal adenocarcinoma.

Ballian N, Lubner MG, Munoz A, Harms BA, Heise CP, Foley EF, Kennedy GD.

J Surg Oncol. 2012 Mar 15;105(4):365-70. doi: 10.1002/jso.22031. Epub 2011 Jul 12.

PMID:
21751219
4.

Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.

Laurent C, Nobili S, Rullier A, Vendrely V, Saric J, Rullier E.

J Am Coll Surg. 2006 Nov;203(5):684-91. Epub 2006 Sep 20.

PMID:
17084330
5.

Results of laparoscopic anterior resection for rectal adenocarcinoma: retrospective analysis of 157 cases.

Pugliese R, Di Lernia S, Sansonna F, Scandroglio I, Maggioni D, Ferrari GC, Costanzi A, Magistro C, De Carli S.

Am J Surg. 2008 Feb;195(2):233-8.

PMID:
18083137
7.

Factors that influence the adequacy of total mesorectal excision for rectal cancer.

Jeyarajah S, Sutton CD, Miller AS, Hemingway D; Leicester Colorectal Specialist Group.

Colorectal Dis. 2007 Nov;9(9):808-15. Epub 2007 Apr 18.

PMID:
17441969
8.

Impact of obesity on operation performed, complications, and long-term outcomes in terms of restoration of intestinal continuity for patients with mid and low rectal cancer.

Aytac E, Lavery IC, Kalady MF, Kiran RP.

Dis Colon Rectum. 2013 Jun;56(6):689-97. doi: 10.1097/DCR.0b013e3182880ffa.

PMID:
23652741
9.

Abdominoperineal resection for rectal cancer at a specialty center.

Nissan A, Guillem JG, Paty PB, Douglas Wong W, Minsky B, Saltz L, Cohen AM.

Dis Colon Rectum. 2001 Jan;44(1):27-35; discussion 35-6.

PMID:
11805560
10.

Surgical treatment of adenocarcinoma of the rectum.

Zaheer S, Pemberton JH, Farouk R, Dozois RR, Wolff BG, Ilstrup D.

Ann Surg. 1998 Jun;227(6):800-11.

11.

The impact of obesity on technical feasibility and postoperative outcomes of laparoscopic left colectomy.

Leroy J, Ananian P, Rubino F, Claudon B, Mutter D, Marescaux J.

Ann Surg. 2005 Jan;241(1):69-76.

12.

The impact of obesity on outcomes following pancreatectomy for malignancy.

Benns M, Woodall C, Scoggins C, McMasters K, Martin R.

Ann Surg Oncol. 2009 Sep;16(9):2565-9. doi: 10.1245/s10434-009-0573-7. Epub 2009 Jun 26.

PMID:
19557479
13.

Operative safety and oncologic outcomes of anal sphincter-preserving surgery with mesorectal excision for rectal cancer: 931 consecutive patients treated at a single institution.

Kim NK, Kim YW, Min BS, Lee KY, Sohn SK, Cho CH.

Ann Surg Oncol. 2009 Apr;16(4):900-9. doi: 10.1245/s10434-009-0340-9. Epub 2009 Feb 7.

PMID:
19198951
14.

Outcomes for abdominoperineal resections are not worse than those of anterior resections.

Chuwa EW, Seow-Choen F.

Dis Colon Rectum. 2006 Jan;49(1):41-9.

PMID:
16283562
15.

Oncologic results following abdominoperineal resection for adenocarcinoma of the low rectum.

Dehni N, McFadden N, McNamara DA, Guiguet M, Tiret E, Parc R.

Dis Colon Rectum. 2003 Jul;46(7):867-74; discussion 874.

PMID:
12847358
16.

Effects of obesity in rectal cancer surgery.

Chern H, Chou J, Donkor C, Shia J, Guillem JG, Nash GM, Paty PB, Temple LK, Wong WD, Weiser MR.

J Am Coll Surg. 2010 Jul;211(1):55-60. doi: 10.1016/j.jamcollsurg.2010.03.010. Epub 2010 May 15.

PMID:
20610249
17.

A national strategic change in treatment policy for rectal cancer--implementation of total mesorectal excision as routine treatment in Norway. A national audit.

Wibe A, Møller B, Norstein J, Carlsen E, Wiig JN, Heald RJ, Langmark F, Myrvold HE, Søreide O; Norwegian Rectal Cancer Group.

Dis Colon Rectum. 2002 Jul;45(7):857-66.

PMID:
12130870
18.

Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial.

den Dulk M, Marijnen CA, Putter H, Rutten HJ, Beets GL, Wiggers T, Nagtegaal ID, van de Velde CJ.

Ann Surg. 2007 Jul;246(1):83-90.

19.

Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.

Fujita S, Akasu T, Mizusawa J, Saito N, Kinugasa Y, Kanemitsu Y, Ohue M, Fujii S, Shiozawa M, Yamaguchi T, Moriya Y; Colorectal Cancer Study Group of Japan Clinical Oncology Group.

Lancet Oncol. 2012 Jun;13(6):616-21. doi: 10.1016/S1470-2045(12)70158-4. Epub 2012 May 15.

PMID:
22591948
20.

Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intention.

De Graaf EJ, Doornebosch PG, Tollenaar RA, Meershoek-Klein Kranenbarg E, de Boer AC, Bekkering FC, van de Velde CJ.

Eur J Surg Oncol. 2009 Dec;35(12):1280-5. doi: 10.1016/j.ejso.2009.05.001. Epub 2009 May 31.

PMID:
19487099

Supplemental Content

Support Center